{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:51:37Z","timestamp":1791888697101,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jgar.2026.09.003","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:42:55Z","timestamp":1789573375000},"page":"184-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antifungal consumption in haematology, intensive care units, and at hospital level in French hospitals in 2024"],"prefix":"10.1016","volume":"51","author":[{"given":"Justine","family":"Gressani-Pellerin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Boug\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Ali-Brandmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Jouzeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lory","family":"Dugravot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Nivoix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Colas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1146-0259","authenticated-orcid":false,"given":"Catherine","family":"Dumartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.09.003_bib0001","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jgar.2026.09.003_bib0002","series-title":"Les infections fongiques, la nouvelle pand\u00e9mie, vraiment\u202f?","year":"2025"},{"key":"10.1016\/j.jgar.2026.09.003_bib0003","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.pharma.2024.12.010","article-title":"\u00c9mergence des r\u00e9sistances aux antifongiques: une menace environnementale rampante\u202f?","volume":"83","author":"Decocq","year":"2025","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.jgar.2026.09.003_bib0004","unstructured":"WHO fungal priority pathogens list to guide research, development and public health action. 2022. Disponible sur: https:\/\/www.who.int\/publications\/i\/item\/9789240060241."},{"key":"10.1016\/j.jgar.2026.09.003_bib0005","unstructured":"WHO. Antifungal agents in clinical and preclinical development: overview and analysis issues its first-ever reports on tests and treatments for fungal infections. 2025 Disponible sur: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/491233fa-c87e-4447-b84f-708c001fc85b\/content."},{"key":"10.1016\/j.jgar.2026.09.003_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0399-077X(14)70265-3","article-title":"M-28: premi\u00e8re \u00e9tude multicentrique de la consommation des antifongiques en \u00e9tablissements de sant\u00e9","volume":"44","author":"Dumartin","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.jgar.2026.09.003_bib0007","unstructured":"Mission SPARES. Surveillance de la consommation des antibiotiques et de la r\u00e9sistance bact\u00e9rienne dans les \u00e9tablissements de sant\u00e9 en 2024 \u2013 M\u00e9thodologie Nationale. 2025. Disponible sur: https:\/\/cpias-grand-est.fr\/wp-content\/files\/2025\/03\/cpias-grand-est-spares-213-10.pdf."},{"key":"10.1016\/j.jgar.2026.09.003_bib0008","series-title":"Guidelines for ATC classification and DDD assignment, 2025","year":"2025"},{"key":"10.1016\/j.jgar.2026.09.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00920-22","article-title":"Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF Network (2012 to 2018)","volume":"13","author":"Bretagne","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2026.09.003_bib0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anrea.2023.11.003","article-title":"Infections fongiques en r\u00e9animation","volume":"10","author":"Soulier-Zaninka","year":"2024","journal-title":"Anesth R\u00e9anim"},{"key":"10.1016\/j.jgar.2026.09.003_bib0011","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/myc.12912","article-title":"Systemic antifungal drug use in Belgium\u2014one of the biggest antifungal consumers in Europe","volume":"62","author":"Goemaere","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2026.09.003_bib0012","unstructured":"NethMap \u2013 MARAN consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. 2022. Disponible sur: https:\/\/swab.nl\/nl\/exec\/file\/download\/197."},{"key":"10.1016\/j.jgar.2026.09.003_bib0013","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/jac\/dkaf269","article-title":"Trends in antifungal use among hospitalized patients in the USA, 2018-23","volume":"80","author":"Smith","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.09.003_bib0014","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.eimc.2024.07.011","article-title":"Trends in antimicrobial consumption at 72 adult and pediatric hospitals in Catalonia. Results of the VINCat Program 2008-2022","volume":"43","author":"Padull\u00e9s","year":"2025","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jgar.2026.09.003_bib0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s15010-015-0742-5","article-title":"Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany","volume":"43","author":"Gross","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2026.09.003_bib0016","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2026.09.003_bib0017","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.09.003_bib0018","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41375-025-02586-7","article-title":"Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)","volume":"39","author":"Pagano","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.jgar.2026.09.003_bib0019","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","article-title":"Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Flowers","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgar.2026.09.003_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/jrms.jrms_1072_21","article-title":"Invasive fungal infections in hematologic malignancies: incidence, management, and antifungal therapy","volume":"28","author":"Shafiee","year":"2023","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.jgar.2026.09.003_bib0021","unstructured":"SPF. Mycoses invasives en France m\u00e9tropolitaine, SPF, PMSI 2001-2010: incidence, l\u00e9talit\u00e9 et tendances. Mycoses invasives en France: \u00e9pid\u00e9miologie, enjeux diagnostiques et th\u00e9rapeutiques. Disponible sur: https:\/\/www.santepubliquefrance.fr\/notices\/mycoses-invasives-en-france-metropolitaine-pmsi-2001-2010-incidence-letalite-et-tendances.-numero-thematique.-mycoses-invasives-en-france-epi."},{"key":"10.1016\/j.jgar.2026.09.003_bib0022","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jgar.2026.09.003_bib0023","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jgar.2026.09.003_bib0024","unstructured":"AP-HP. Recommandations sur les antifongiques. 2018 Disponible sur: https:\/\/ageps.aphp.fr\/wp-content\/blogs.dir\/68\/files\/2019\/01\/Recommandations-sur-le-bon-usage-des-antifongiques-dec-2018.pdf."},{"key":"10.1016\/j.jgar.2026.09.003_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/myc.12329","article-title":"Antifungal stewardship in daily practice and health economic implications","volume":"58","author":"Mu\u00f1oz","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2026.09.003_bib0026","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12879-015-0809-z","article-title":"How much European prescribing physicians know about invasive fungal infections management?","volume":"15","author":"Valerio","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2026.09.003_bib0027","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jac\/dky389","article-title":"Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010\u201316","volume":"74","author":"Whitney","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.09.003_bib0028","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/jac\/dks256","article-title":"Adherence to recommendations for the use of antifungal agents in a tertiary care hospital","volume":"67","author":"Nivoix","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.09.003_bib0029","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1469-0691.12622","article-title":"Antifungal stewardship in invasive Candida infections","volume":"20","author":"Ruhnke","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2026.09.003_bib0030","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core recommendations for antifungal stewardship: a statement of the Mycoses Study Group Education and Research Consortium","volume":"222","author":"Johnson","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2026.09.003_bib0031","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s15010-013-0431-1","article-title":"A 6-year antifungal stewardship programme in a teaching hospital","volume":"41","author":"Mondain","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2026.09.003_bib0032","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s15010-018-01264-4","article-title":"Appropriate use of antifungals: impact of an antifungal stewardship program on the clinical outcome of candidaemia in a French University Hospital","volume":"47","author":"Benoist","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2026.09.003_bib0033","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/myc.13098","article-title":"How can we optimise antifungal use in a solid organ transplant centre? Local epidemiology and antifungal stewardship implementation: a single-centre study","volume":"63","author":"Mularoni","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2026.09.003_bib0034","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jac\/dkaf044","article-title":"Assessing the appropriateness of antifungal prescribing: key results from the implementation of a novel audit tool in Australian hospitals","volume":"80","author":"Khanina","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.09.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106255","article-title":"Impact of a non-compulsory antifungal stewardship program on overuse and misuse of antifungal agents in a tertiary care hospital","volume":"57","author":"Markogiannakis","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2026.09.003_bib0036","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. Disponible sur: https:\/\/base-donnees-publique.medicaments.gouv.fr\/medicament\/62994632\/extrait#4.1._Indications_th%C3%A9rapeutique."}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:29:38Z","timestamp":1791887378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"alternative-id":["S2213716526001700"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.09.003","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal consumption in haematology, intensive care units, and at hospital level in French hospitals in 2024","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}